We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

3D rendered image of blue iridescent <i>E. Coli</i> bacteria.

Nanoplastics May Make Foodborne Pathogens More Virulent

A production line of COVID-19 vaccines in vials, representing production of the newly approved Novavax COVID vaccine.

FDA Approves Novavax COVID Vaccine, But With Restrictions

A young woman wearing a baseball cap and face mask, looking to the side of the camera.

Nanosheet Filters Capture Virus-Sized Particles Without Sacrificing Breathability

Opioid Addiction Drug Restores Function in Cells From Long COVID Patients

Cold Sore Virus Linked to Higher Alzheimer’s Risk

Blood and Urine Biomarkers Reveal How Much Ultra-Processed Food We Eat

News

Solexa Strengthens Patent Position in Next-Generation Genetic Analysis

These advances relate to the use of reversible-terminator chemistry in DNA Sequencing-by-Synthesis.

Twin Molecular Scissors Link Creation of MicroRNAs With Gene-Silencing

Researchers have identified a two-protein complex which controls the earliest steps in the creation of miRNAs.

Hybrigenics Names New CEO and Board Chairman

Remi Delansorne has been appointed as CEO and Daan Ellens as Chairman of the Board.

Sigma-Aldrich Names Jai Nagarkatti as Chief Executive Officer

The appointment will be effective on January 1, 2006.

DxS Launches Bespoke Consultancy and Training Service

Pharmaceutical and clinical research customers can receive training on pharmacogenomics and personalized medicine.

Illumina to Conduct Large-Scale Genotyping Study

Study Designed to Understand Genetic Susceptibility, Mechanisms of Disease Progression, and Cancer Therapy Management.

Metabolon Appoints Chief Scientific Officer

Dr. Michael Milburn has been appointed as Chief Scientific Officer.

Affibody and NIH to Develop Molecular In Vivo Imaging Agents

Affibody will design and develop engineered Affibody® molecules specific for a receptor protein, HER2.

Varian Acquires Polymer Laboratories

This acquisition is part of Varian's strategy to strengthen the Company's product portfolio.

Sharper X-Rays of Cell's Ribosome Could Lead to Better Antibiotics

A sharper picture of the nano-machine promises to help researchers explain how some types of antibiotics work

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter